Lilly Joins $1 Trillion Club in Weight-Loss Drug Fueled Climb

The world’s largest drugmaker, Eli Lilly & Co., just notched another milestone: it’s the first health-care company to cross the $1 trillion threshold as investors bet big on the drugmaker’s weight-loss medicines.

Shares of Lilly rose as much as 1.7% on Friday, pushing its market value to about $1 trillion, according to data compiled by Bloomberg. With the advance, Lilly has cemented its position as the first pharmaceutical company and the second US firm outside of the technology industry to achieve the milestone.

Read more: Lilly, Novo to Start Selling Obesity Drugs Directly to Employers